Incyte (INCY) Enterprise Value (2010 - 2026)
Incyte (INCY) posted Enterprise Value of -$4.0 billion for Q1 2026, down 12.15% on a QoQ basis from -$3.6 billion in Q4 2025, and down 66.72% year-over-year from -$12.1 billion in Q1 2025.
Incyte (INCY) Enterprise Value (2010 - 2026) Analysis & Trends
Incyte's Enterprise Value history runs 17 years deep, the most recent figure standing at -$4.0 billion for Q1 2026.
- Quarterly Enterprise Value fell 66.72% year-over-year to -$4.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.0 billion (down 66.72% YoY) and the FY2025 annual result came in at -$3.6 billion, down 65.92% from the prior year.
- Enterprise Value was -$4.0 billion for Q1 2026 at Incyte, down from -$3.6 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.1 billion in Q2 2024 and bottomed at -$4.0 billion in Q1 2026.
- A 5-year average of -$2.9 billion and a median of -$3.0 billion in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value surged 69.12% — and 2025, when it slumped 129.08%.
- Incyte's Enterprise Value stood at -$3.2 billion in 2022, then retreated by 12.88% to -$3.7 billion in 2023, then surged by 40.97% to -$2.2 billion in 2024, then plunged by 65.92% to -$3.6 billion in 2025, then fell by 12.15% to -$4.0 billion in 2026.
- Business Quant data shows INCY's Enterprise Value at -$4.0 billion in Q1 2026, -$3.6 billion in Q4 2025, and -$2.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | -4.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.02 Bn |
| Dec 31, 2025 | -3.58 Bn |
| Sep 30, 2025 | -2.93 Bn |
| Jun 30, 2025 | -2.42 Bn |
| Mar 31, 2025 | -2.41 Bn |
| Dec 31, 2024 | -2.16 Bn |
| Sep 30, 2024 | -1.77 Bn |
| Jun 30, 2024 | -1.06 Bn |
| Mar 31, 2024 | -3.85 Bn |
| Dec 31, 2023 | -3.66 Bn |
| Sep 30, 2023 | -3.52 Bn |
| Jun 30, 2023 | -3.42 Bn |
| Mar 31, 2023 | -3.11 Bn |
| Dec 31, 2022 | -3.24 Bn |
| Sep 30, 2022 | -2.98 Bn |
| Jun 30, 2022 | -2.72 Bn |
| Mar 31, 2022 | -2.54 Bn |
| Dec 31, 2021 | -2.35 Bn |
| Sep 30, 2021 | -2.28 Bn |
| Jun 30, 2021 | -2.08 Bn |